美國巴金森氏症深部腦部刺激市場：市場規模、佔有率、趨勢分析（按產品）、競爭分析、細分預測（2025-2030）

美國帕金森氏症深部腦部刺激市場的成長與趨勢

根據 Grand View Research, Inc. 的新報告，美國帕金森氏症深部腦部刺激市場規模預計到 2030 年將達到 8.495 億美元，2025 年至 2030 年的複合年成長率為 7.19%。

這個市場受到多種因素的推動，包括新產品的推出和醫療成本的上漲。不斷增加的監管核准在推動市場成長方面發揮關鍵作用，因為它們為醫療保健專業人員和患者提供了有關這些設備的安全性和有效性的一定程度的保證，從而促進了它們在臨床環境中的應用。例如，FDA 於 2024 年 1 月批准雅培的 Liberta RC DBS 設備，標誌著推動 PD治療性介入的重要里程碑。

Liberta RC DBS 是同類產品中最小的可充電 DBS 設備，並引入了 NeuroSphere Virtual Clinical 等顯著的技術特性，可實現遠端程式設計功能。此項監管部門的核准凸顯了該設備遵守嚴格的安全性和有效性標準，並將其定位為神經調節領域的先驅解決方案。雅培為 Liberta RC DBS 增加遠端程式設計功能，在策略上契合了整體醫療保健趨勢，提高了患者的便利性，並擴大了醫學界對該設備的接受度。

雅培公司最近獲得 FDA 批准的 Liberta RC DBS 預計將改變市場動態，增加美國DBS 領域對 PD 治療的興趣和採用。

美國巴金森氏症深部腦部刺激市場：概述

• 雙通道部分將在 2024 年以 59.04% 的最大收益佔有率引領市場，預計在 2025 年至 2030 年期間將實現最快的複合年成長率。
• 這一成長可歸因於技術進步和行業主要企業的新產品推出。
• 推動市場成長的主要因素之一是用於治療帕金森氏症 (PD) 的深部腦部刺激 (DBS) 設備越來越獲得監管機構的核准。
• 監管部門的核准為製造商提供了行銷和商業化設備的機會，促進了競爭。
• 這種競爭可能會帶來技術進步和設備設計的改進，從而產生更具成本效益的選擇，進一步促進市場成長。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第 3美國。

• 市場聯動展望
  • 附隨市場展望
• 市場動態
  • 市場促進因素分析
  • 市場限制分析
  • 市場機會
  • 市場挑戰
• 美國巴金森氏症深部腦部刺激市場：分析工具
  • 產業分析：波特五力分析
  • PESTEL 分析

第 4美國。

• 細分儀表板
• 美國巴金森氏症深部腦部刺激市場波動
• 美國帕金森氏症深部腦部刺激市場：按產品分類的市場規模和趨勢分析（2018-2030 年）
• 單通道
• 雙通道

第5章 競爭格局

• 市場參與企業分類
• 主要企業簡介
  • ABBOTT
  • Medtronic
  • Boston Scientific Corporation
• 熱圖分析/企業市場分析
• 各公司市場佔有率評估分析分析（2024 年）
• 其他主要企業名單

U.S. Deep Brain Stimulation In Parkinson's Disease Market Growth & Trends:

The U.S. deep brain stimulation in parkinson's disease market size is anticipated to reach USD 849.50 million by 2030, registering a CAGR of 7.19% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by various factors, such as novel product launches, and rising healthcare expenditure. Increasing regulatory approvals play a crucial role in driving market growth as they provide a level of assurance to healthcare professionals and patients regarding the safety and efficacy of these devices, thereby encouraging their adoption in clinical practice. For instance, in January 2024, FDA clearance for Abbott's Liberta RC DBS Device represented a significant milestone in advancing therapeutic interventions for PD.

Liberta RC DBS, distinguished as the smallest rechargeable DBS device in its class, introduced notable technological features, such as the NeuroSphere Virtual Clinical, enabling remote programming capabilities. This regulatory endorsement underscored adherence of the device to stringent safety and efficacy standards and positioned it as a pioneering solution in the field of neuromodulation. The incorporation of remote programming capabilities in the Liberta RC DBS device by Abbott aligns strategically with prevailing healthcare trends, augmenting patient convenience and broadening the device's acceptance within the medical community.

Abbott's recent achievement of securing FDA clearance for Liberta RC DBS is anticipated to catalyze transformative shifts in market dynamics, propelling heightened interest and fostering increased adoption within the U.S. DBS sector for PD treatment.

U.S. Deep Brain Stimulation In Parkinson's Disease Market Report Highlights:

• The dual-channel segment led the market with the largest revenue share of 59.04% in 2024 and is expected to register at the fastest CAGR from 2025 to 2030
• This growth is attributed to technological advancements and novel product launches by industry key players
• One of the key factors driving the market growth is increasing regulatory approval for deep brain stimulation (DBS) devices in Parkinson's disease (PD) treatment
• Regulatory approvals offer opportunities for manufacturers to market and commercialize their devices, fostering competition
• This competition often results in technological advancements, device design improvements, and potentially more cost-effective options, which further contribute to market growth

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Deep Brain Stimulation In Parkinson's Disease Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological Advancements In Deep Brain Stimulation Devices
    • 3.2.1.2. Increasing Prevalence Of Parkinson's Disease
    • 3.2.1.3. Government Funding For Research And Development
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Complex Regulatory Framework
    • 3.2.2.2. Risk And Complications Associated With DBS Surgery
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Increasing Clinical Studies On DBS Assessments For Parkinson's Disease
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Alternatives For DBS System
• 3.3. U.S. Deep Brain Stimulation In Parkinson's Disease Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Deep Brain Stimulation In Parkinson's Disease Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Deep Brain Stimulation In Parkinson's Disease Market Movement Analysis
• 4.3. U.S. Deep Brain Stimulation In Parkinson's Disease Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Single-Channel
  • 4.4.1. Single-Channel U.S. Deep Brain Stimulation In Parkinson's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Dual-Channel
  • 4.5.1. Dual-Channel U.S. Deep Brain Stimulation In Parkinson's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Market Participant Categorization
• 5.2. Key Company Profiles
  • 5.2.1. ABBOTT
    • 5.2.1.1. Company Overview
    • 5.2.1.2. Financial Performance
    • 5.2.1.3. Service Benchmarking
    • 5.2.1.4. Strategic Initiatives
  • 5.2.2. Medtronic
    • 5.2.2.1. Company Overview
    • 5.2.2.2. Financial Performance
    • 5.2.2.3. Service Benchmarking
    • 5.2.2.4. Strategic Initiatives
  • 5.2.3. Boston Scientific Corporation
    • 5.2.3.1. Company Overview
    • 5.2.3.2. Financial Performance
    • 5.2.3.3. Service Benchmarking
    • 5.2.3.4. Strategic Initiatives
• 5.3. Heat Map Analysis/ Company Market Position Analysis
• 5.4. Estimated Company Market Share Analysis, 2024
• 5.5. List of Other Key Market Players

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 U.S. Deep Brain Stimulation In Parkinson's Disease Market, by Product, 2018 - 2030 (USD Million)
• Table 4 Participant's Overview
• Table 5 Financial Performance
• Table 6 Product Benchmarking
• Table 7 Strategic Initiatives

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Deep Brain Stimulation In Parkinson's Disease Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Product Marketplace: Key Takeaways
• Fig. 14 U.S. Deep Brain Stimulation In Parkinson's Disease Market, for Single-channel, 2018 - 2030 (USD Million)
• Fig. 15 U.S. Deep Brain Stimulation In Parkinson's Disease Market, for Dual-channel, 2018 - 2030 (USD Million)